Subcutaneous Infliximab [CT-P13], a True Biologic 2.0. Real Clinical Practice Multicentre Study.
Huguet JM, García-Lorenzo V, Martí L, Paredes JM, Ramírez JJ, Pastor M, Ruiz L, Sanahuja A, Timoneda P, Sanchís L, Pérez GA, Boscá-Watts MM.
Huguet JM, et al. Among authors: pastor m.
Biomedicines. 2022 Aug 30;10(9):2130. doi: 10.3390/biomedicines10092130.
Biomedicines. 2022.
PMID: 36140230
Free PMC article.